Artivion, Inc. (AORT)
$21.26+0.24%Close
SELLCRISIS · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.0B
- Beta
- 1.22
- P/E (TTM)
- -366.44
- Short % float
- 7.86%
- Days to cover
- 5.5
- SI change
- +10.3%
- 1W
- -4.71%
- 1M
- -13.75%
- vs SPY 1W
- -5.87%
- vs SPY 1M
- -16.74%
Industry peers
FMP comparable companies · ranked by market cap
- COGTSELLCogent Biosciences, Inc.$5.3BRECOVERYQ 13$31.00+3.06%
- LFSTSELLLifeStance Health Group, Inc.$4.8BBEARQ -5$12.42+2.99%
- ITGRBUYInteger Holdings Corporation$4.3BBULLQ 19$126.61-0.03%
- LQDASELLLiquidia Corporation$2.4BCRISISQ 12$27.38-2.28%
- BKDSELLBrookdale Senior Living Inc.$2.4BCRISISQ 5$10.12-7.07%
- ADUSSELLAddus HomeCare Corporation$2.1BBEARQ 18$114.33+0.06%
- INSPSELLInspire Medical Systems, Inc.$2.0BRECOVERYQ 14$68.89+3.30%
- ARDTBUYArdent Health Inc.$1.6BRECOVERYQ -12$11.30+2.08%
- PRCTSELLPROCEPT BioRobotics Corporation$1.0BRECOVERYQ -3$18.40+2.79%
- SSIISELLSS Innovations International, Inc.$529MCRISISQ 16$2.65+0.76%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AORT?
- LOPJLB’s latest quantitative signal on Artivion, Inc. (AORT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AORT in?
- Artivion, Inc. (AORT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Artivion, Inc. (AORT) do?
- Artivion Inc. is a global company that develops, produces, and supplies medical devices and implantable human tissues. Its product range includes BioGlue, a polymer derived from bovine blood protein combined with a cross-linking agent, utilized in cardiac, vascular, neurological, and pulmonary surgical applications. The company also offers heart preservation services and the PhotoFix bovine per…